ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway

ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway

10.1586/era.12.17

Saved in:
Bibliographic Details
Main Authors: Ou, S.-H.I., Tan, J., Yen, Y., Soo, R.A.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Published: 2014
Subjects:
ALK inhibitor
CD74-ROS1
cholangiocarcinoma
crizotinib
driver mutation
FIG-ROS1
glioblastoma multiforme
non-small-cell lung cancer
personalized medicine
ROS1 inhibitor
ROS1 receptor tyrosine kinase
SLC34A2-ROS1
Online Access:http://scholarbank.nus.edu.sg/handle/10635/116889
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/116889

Similar Items